This was the stock's third consecutive day of losses.

Kenvue Inc . (NYSE:KVUE), the consumer health company spun off from Johnson & Johnson in 2023, finds itself at a critical juncture as it navigates its first full year as an independent entity. The ...

Dividends can be a great way to generate income from stocks, no matter what the market is doing. But only if the companies ...

On the Heels of its 10th Anniversary, the Brand's Iconic Hydro Boost Collection Is Revealing a Juicy, Fresh Take SKILLMAN, ...

RBC Capital analyst Nik Modi maintained a Hold rating on Kenvue, Inc. (KVUE – Research Report) today and set a price target of $24.00. The ...

Kenvue (NYSE:KVUE – Get Free Report) is expected to be issuing its quarterly earnings data before the market opens on ...

L’Oréal veteran Penelope Giraud will lead the direction of the company’s beauty brands Neutrogena, Aveeno and Dr. Ci Labo in ...

Barclays analyst Lauren Lieberman maintained a Hold rating on Kenvue, Inc. (KVUE – Research Report) today and set a price target of $21.00. The ...

LISTERINE®, a flagship oral care brand under Kenvue, announced its upcoming participation in AEEDC 2025, the world's largest dental health ...

Kenvue Inc. (NYSE: KVUE) announces global sensation Tate McRae as the newest face of Neutrogena®. This announcement marks the ...

Kenvue Inc. closed 12.96% below its 52-week high of $24.46, which the company reached on November 26th.